Position in RPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$37,723,368
+$5,051,510 QoQ
Shares Held
786,395
-7.0% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. RPRX ranks #19 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,723,368 | 786,395 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $32,671,858 | 845,545 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,645,619 | 783,606 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $39,778,705 | 1,104,044 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $49,784,216 | 1,599,236 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,369,939 | 798,508 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $27,044,674 | 955,980 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,849,977 | 904,436 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $753,297 | 24,804 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,230,245 | 186,196 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $405,661 | 14,947 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $376,945 | 10,462 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,083,022 | 128,619 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,921,326 | 147,370 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,121,440 | 312,118 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,073,002 | 309,882 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $19,637,840 | 492,794 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $16,439,869 | 454,894 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,963,031 | 487,022 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $23,550,699 | 539,906 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $30,386,105 | 607,115 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||